Engaging Family Members During Early SUD Treatment: A Hybrid Trial

NCT07579299 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-05-14

No results posted yet for this study

Summary

The goal of this study is a fractional factorial optimization trial to optimize engagement in a CRAFT program for family members with loved ones in outpatient treatment for a substance use disorder.

This study aims to identify family engagement strategies that are feasible, acceptable, and appropriate and effective in increasing family member initiation with CRAFT. Participants will complete an iterative, online process where they will evaluate and rank different engagement strategies to identify the most optimal in increasing engagement and then participate in an optimization trial to identify which strategies were most effective in increasing family member engagement.

Conditions

  • Substance Use Disorder (SUD)

Interventions

BEHAVIORAL

Engagement Strategy 1

Engagement Strategy

BEHAVIORAL

Engagement Strategy 2

Engagement Strategy

BEHAVIORAL

Engagement Strategy 3

Engagement Strategy

BEHAVIORAL

Engagement Strategy 4

Engagement Strategy

BEHAVIORAL

Placebo

No engagement strategies

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • RAND

    collaborator OTHER
  • Northern California Institute of Research and Education

    collaborator OTHER
  • Family Health Centers of San Diego

    collaborator OTHER
  • Stanford University

    lead OTHER

Principal Investigators

  • Karen Osilla, PhD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-15
Primary Completion
2027-01-31
Completion
2027-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07579299 on ClinicalTrials.gov